Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

Researchers have launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced ...

In litigation over the past two years, CureVac alleged the BioNTech and Pfizer vaccine for Covid-19 infringed CureVac patents ...

Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory ...

CDC employees were given the option to work from home on Monday following the shooting that targeted the agency’s ...

No, I am not a socialist, despite having been on the Yale Law School faculty for most of my career.  But nonetheless, I favor Zohran Mamdani, an avowed “democratic socialist” — and according to ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with ...

THESE WERE JUST THREE of the specious claims Kennedy made; there were others, too. But it’s likely that for many people who ...

CDC employees across all of the agency’s campuses will be teleworking today, after a gunman shot multiple rounds into four ...

Excerpts from recent editorials in the United States and abroad: ___ Aug. 8 The New York Times say Trump is letting TikTok, and China, win Not so long ago, the confrontation between the U.S.

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...